For example, Yamada et al. reported that the promoter and exon 1 of FLT1 were aberrantly methylated in prostate cancer cell lines and tumor tissue samples, whereas benign prostate tissue samples were hypomethylated [30]. The gene discussed is FLT1; the disease is neoplasm.